Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method

Isavuconazole is a novel expanded-spectrum triazole, which has recently been approved by the FDA as an orphan drug to treat invasive aspergillosis and is currently being studied in phase III clinical trials for invasive candidiasis. The susceptibility of relatively few clinical isolates has been rep...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Howard, Susan J., Lass-Flörl, Cornelia, Cuenca-Estrella, Manuel, Gomez-Lopez, Alicia, Arendrup, Maiken C.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2013
נושאים:
Susceptibility
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3811258/
https://ncbi.nlm.nih.gov/pubmed/23959309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01111-13
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים